Aurothiomalate tetramer (sodium)
Aurothiomalate tetramer sodium, an Aurothiomalate sodium (HY-106381) tetrameric form, is antiarthritic gold agent. Aurothiomalate sodium is a potent and selective oncogenic PKCι signaling inhibitor[1].
Product Specifications
UNSPSC
12352211
Target
PKC
Related Pathways
Epigenetics; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
98.0
Smiles
O=C(O[Na])C(S[Au])CC(O[Na])=O.[4]
References & Citations
[1]Farivash Darabi, et al. Reactions of model proteins with aurothiomalate, a clinically established gold (I) drug: The comparison with auranofin. J Inorg Biochem. 2015 Aug:149:102-7.|[2]Roderick P Regala, et al. Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells. Cancer Res. 2008 Jul 15;68 (14) :5888-95.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15336880 1 Vial
Lentiviral human IGHMBP2 shRNA (UAS) - Lentiviral human IGHMBP2 shRNA (UAS, RFP) plasmid
Ask
View Details 
MBS6346936-01 0.2 mL
Sgk223, NT (Sgk223, D8Ertd82e, Tyrosine-protein kinase SgK223, Sugen kinase 223) (FITC)
Ask
View Details MBS6346936-02 5x 0.2 mL
Sgk223, NT (Sgk223, D8Ertd82e, Tyrosine-protein kinase SgK223, Sugen kinase 223) (FITC)
Ask
View Details